Theelen, W. S. M. E., Peulen, H. M. U., Lalezari, F., van der Noort, V., de Vries, J. F., Aerts, J. G. J. V., . . . Baas, P. (2019). Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non-Small Cell Lung Cancer: Results of the PEMBRO-RT Phase 2 Randomized Clinical Trial. JAMA oncology, 5(9), 1276. https://doi.org/10.1001/jamaoncol.2019.1478
Chicago-Zitierstil (17. Ausg.)Theelen, Willemijn S M E., et al. "Effect of Pembrolizumab After Stereotactic Body Radiotherapy Vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non-Small Cell Lung Cancer: Results of the PEMBRO-RT Phase 2 Randomized Clinical Trial." JAMA Oncology 5, no. 9 (2019): 1276. https://doi.org/10.1001/jamaoncol.2019.1478.
MLA-Zitierstil (9. Ausg.)Theelen, Willemijn S M E., et al. "Effect of Pembrolizumab After Stereotactic Body Radiotherapy Vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non-Small Cell Lung Cancer: Results of the PEMBRO-RT Phase 2 Randomized Clinical Trial." JAMA Oncology, vol. 5, no. 9, 2019, p. 1276, https://doi.org/10.1001/jamaoncol.2019.1478.